Co-delivery of carbonic anhydrase IX inhibitor and doxorubicin as a promising approach to address hypoxia-induced chemoresistance-Reference-Cited by-同舟云学术

Co-delivery of carbonic anhydrase IX inhibitor and doxorubicin as a promising approach to address hypoxia-induced chemoresistance

Published:2022-07-17 Issue:1 Volume:29 Page:2072-2085
ISSN:1071-7544
Container-title:Drug Delivery
language:en
Short-container-title:Drug Delivery

Author:

Amin Muhammad Umair¹,Ali Sajid¹²,Ali Muhammad Yasir¹³,Fuhrmann Dominik C.⁴,Tariq Imran¹⁵,Seitz Benjamin S.¹,Preis Eduard¹,Brüßler Jana¹,Brüne Bernhard⁴,Bakowsky Udo¹

Affiliation:

1. Department of Pharmaceutics and Biopharmaceutics, University of Marburg, Marburg, Germany

2. Department of Chemistry, Angström Laboratory, Uppsala University, Uppsala, Sweden

3. Faculty of Pharmaceutical Sciences, GC University Faisalabad, Faisalabad, Pakistan

4. Institute of Biochemistry I, Faculty of Medicine, Goethe-University Frankfurt, Frankfurt, Germany

5. Punjab University College of Pharmacy, University of Punjab, Lahore, Pakistan

Funder

German Academic Exchange Service

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/10717544.2022.2092234

Reference62 articles.

1. Surface functionalization of polymeric nanoparticles for tumor drug delivery: approaches and challenges

2. Magnetic resonance activatable thermosensitive liposomes for controlled doxorubicin delivery

3. Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp

4. Targeted ErbB3 cancer therapy: A synergistic approach to effectively combat cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Camptothecin-loaded mesoporous silica nanoparticles functionalized with CpG oligodeoxynucleotide as a new approach for skin cancer treatment;International Journal of Pharmaceutics;2024-07

2. Emerging tendencies for the nano-delivery of gambogic acid: a promising approach in oncotherapy;RSC Advances;2024